Stay updated on Upadacitinib in Giant Cell Arteritis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib in Giant Cell Arteritis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-23T01:46:58.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T05:54:24.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial on giant cell arteritis (GCA), while also adding a new revision number.
    Difference
    9%
    Check dated 2025-04-16T14:45:28.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding new dates of February 19, 2025, and March 7, 2025.
    Difference
    0.1%
    Check dated 2025-04-09T10:11:19.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page has been updated with new dates for results postings and the last update, reflecting a more current timeline. Additionally, the revision number has changed from v2.14.2 to v2.14.3, indicating a new version of the content.
    Difference
    0.4%
    Check dated 2025-04-01T23:37:24.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The webpage has been updated to include new results and objectives for a study on upadacitinib, with specific details on the study's periods, safety, and efficacy data. Additionally, several locations and duplicate entries have been added or removed, reflecting changes in the study's site listings.
    Difference
    59%
    Check dated 2025-03-11T04:48:34.000Z thumbnail image

Stay in the know with updates to Upadacitinib in Giant Cell Arteritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.